Endo Int'l (ENDP) wins appeal to block generic versions of Fortesta - Bloomberg
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Endo Int'l (NASDAQ: ENDP) wins appeal to block generic versions of Fortesta, according o Bloomberg.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wabtec (WAB), Faiveley Agree to Consent Decree - Bloomberg
- Buffalo Wild Wings (BWLD) November 135 straddle priced for movement of 10.4%
- Wabtec (WAB) Announces DOJ Filing of Proposed Consent Decree Related to Faiveley Deal; Calls for Asset Sales
Create E-mail Alert Related CategoriesFDA, Litigation, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!